Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

NCT06895369 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck

NCT04397341 ·Status: COMPLETED ·Phase: PHASE2

Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas

NCT02776163 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer

NCT01689194 ·Status: COMPLETED ·Phase: PHASE2

Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT01412229 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

NCT01326559 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer

NCT00226239 ·Status: COMPLETED ·Phase: PHASE2

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma

NCT06575322 ·Status: RECRUITING

Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN

NCT03117257 ·Status: UNKNOWN ·Phase: PHASE2

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

NCT02923258 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

NCT01080066 ·Status: COMPLETED

Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

NCT00868491 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT01086826 ·Status: COMPLETED ·Phase: PHASE3

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

NCT02126969 ·Status: COMPLETED ·Phase: PHASE2

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

NCT00509665 ·Status: COMPLETED ·Phase: PHASE2

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma

NCT06576180 ·Status: RECRUITING

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

NCT02639858 ·Status: UNKNOWN ·Phase: PHASE2

Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma

NCT02016417 ·Status: UNKNOWN ·Phase: PHASE2

Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma

NCT05252429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

NCT04616196 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor

NCT04766827 ·Status: UNKNOWN ·Phase: PHASE4

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

NCT02290145 ·Status: RECRUITING ·Phase: PHASE2

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)

NCT05027204 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

NCT00248560 ·Status: COMPLETED ·Phase: PHASE2

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT01289522 ·Status: COMPLETED ·Phase: PHASE2